Ketofaet-DS Tablet contains Alpha Ketoanalogue (NA), a specialized pharmaceutical agent used primarily as a dietary supplement in the management of chronic kidney disease (CKD). This compound serves as a nitrogen-free analogue of essential amino acids, facilitating protein synthesis while minimizing nitrogenous waste accumulation, thus reducing the metabolic burden on compromised renal function. Ketofaet-DS is indicated for patients with CKD stages 3 to 5, particularly those on low-protein diets, to prevent protein malnutrition and delay the progression of renal impairment. By providing essential ketoanalogues, the tablet supports anabolic processes without contributing to azotemia, a common complication in renal insufficiency. The medication is typically administered orally, with dosage individualized based on the patient’s renal status, nutritional requirements, and physician assessment. Ketofaet-DS should be used under strict medical supervision, alongside dietary modifications and routine monitoring of renal parameters, electrolyte balance, and nutritional status. Adverse effects are generally minimal but may include gastrointestinal discomfort or allergic reactions in rare cases. This product is contraindicated in patients with hypersensitivity to its components or in acute renal failure. Ketofaet-DS Tablet represents an integral component of conservative management strategies aimed at optimizing nutritional status and preserving residual kidney function in CKD patients.